Pneumococcal polysaccharide vaccine solution for injection 0.5ml vials
Pneumococcal vaccine
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
5 branded products available
Part of the Pneumovax brand family (generic: Pneumococcal vaccine)
MHRA licensed products
View all licensed products for Pneumococcal vaccine on the MHRA register
Pneumococcal polysaccharide vaccine solution for injection 0.5ml vials
Pneumococcal polysaccharide vaccine solution for injection 0.5ml vials
Pneumococcal polysaccharide vaccine solution for injection 0.5ml vials
Alliance Healthcare (Distribution) Ltd
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(5)
Vaccine uptake in the general population (NG218)
Vaccine uptake in under 19s (QS145)
Pneumonia: diagnosis and management (NG250)
Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (NG240)
Neonatal infection: antibiotics for prevention and treatment (NG195)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 21 · Randomised trials: 21 · 1984–2026
Showing the 50 most relevant studies, sorted by most relevant.
G. Falkenhorst, C. Remschmidt, T. Harder, et al.
PLoS ONE, 2017
C. Hua, Thomas Barnetche, Bernard Combe, et al.
Arthritis Care & Research, 2013
- Rituximab
- Influenza Vaccines
- Methotrexate
Hannah Kraicer-Melamed, Shauna O’Donnell, C. Quach
Vaccine, 2016
F. Cutts, Syed M. A. Zaman, G. Enwere, et al.
Lancet, 2005
- Gambia
- Immunization Schedule
- Pneumococcal Infections
Katherine L. O’Brien, Lawrence H. Moulton, Raymond Reid, et al.
The Lancet, 2003
- Heptavalent Pneumococcal Conjugate Vaccine
- Arizona
- Immunization Schedule
Takaya Maruyama, Osamu Taguchi, Michael S. Niederman, et al.
BMJ, 2010
- Nursing Homes
- Homes for the Aged
- Institutionalization
A. Palmu, J. Jokinen, D. Borys, et al.
Lancet, 2012
Eelko Hak, Diederick E. Grobbee, E. A. M. Sanders, et al.
PubMed, 2008
- Pneumonia, Pneumococcal
- Streptococcus pneumoniae
- Pneumococcal Vaccines
J. Chalmers, J. Campling, A. Dicker, et al.
BMC Pulmonary Medicine, 2016
Jennifer L. Farrar, Lana Childs, Mahamoudou Ouattara, et al.
Pathogens, 2022
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Structured knowledge from the free knowledge base
Molecular structure
ATC classifications (Wikidata)
Linked open data from Wikidata (Q2100023), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. Molecular structure images from Wikimedia Commons.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.